Alanna Temme is named as a lobbyist on federal disclosure filings for 31 clients through Lmh Strategic Solutions and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Pharmacy, Health Issues, Medicare/Medicaid and Trade (domestic/foreign).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | Q3 2026 | Medicare/Medicaid, Pharmacy |
| PUBLIC STRATEGIES WASHINGTON OBO AMERICAN ASSOCIATION OF NURSE ANESTHESIOLOGY | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| UNIVERSITY OF LOUISVILLE HEALTH | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| STEALTH BIOTHERAPEUTICS INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Pharmacy, Health Issues |
| SAVARA INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Pharmacy, Health Issues |
| REZOLUTE, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Health Issues |
| REGENXBIO INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Pharmacy, Health Issues |
| PTC THERAPEUTICS, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | LMH STRATEGIC SOLUTIONS | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Pharmacy |
| NEUROPACE, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| NATERA, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| MIRUM PHARMACEUTICALS, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Health Issues |
| MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Pharmacy |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Health Issues |
| IONIS PHARMACEUTICALS, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Health Issues |
| INSMED INCORPORATED | LMH STRATEGIC SOLUTIONS | Q3 2026 | Trade (domestic/foreign) |
| INCYTE CORPORATION | LMH STRATEGIC SOLUTIONS | Q2 2026 | Medicare/Medicaid, Pharmacy, Health Issues |
| HARMONY BIOSCIENCES | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Pharmacy, Health Issues |
| GLAXOSMITHKLINE LLC | LMH STRATEGIC SOLUTIONS | Q3 2026 | Pharmacy, Health Issues |
| ERISA INDUSTRY COMMITTEE (ERIC) | LMH STRATEGIC SOLUTIONS | Q3 2026 | Health Issues |
| BICYCLE THERAPEUTICS | LMH STRATEGIC SOLUTIONS | Q3 2026 | Pharmacy, Health Issues |
| AVADEL PHARMACEUTICALS, PLC | LMH STRATEGIC SOLUTIONS | Q2 2026 | Pharmacy |
| ARDELYX, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Pharmacy, Health Issues |
| ALNYLAM PHARMACEUTICALS, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| ALKERMES, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| TRAVERE THERAPEUTICS, INC. | LMH STRATEGIC SOLUTIONS | Q1 2026 | Pharmacy |
| NEUROCRINE BIOSCIENCES, INC. | LMH STRATEGIC SOLUTIONS | Q4 2025 | Medicare/Medicaid, Pharmacy |
| BIOMARIN PHARMACEUTICAL, INC. | LMH STRATEGIC SOLUTIONS | Q4 2025 | Medicare/Medicaid, Pharmacy |
| EXELIXIS, INC. | LMH STRATEGIC SOLUTIONS | Q4 2025 | Medicare/Medicaid, Pharmacy |
| ACADIA PHARMACEUTICALS | LMH STRATEGIC SOLUTIONS | Q4 2025 | Medicare/Medicaid, Pharmacy |
| ORCHARD THERAPEUTICS NORTH AMERICA | LMH STRATEGIC SOLUTIONS | Q2 2025 | Health Issues |
| RARE DISEASE COMPANY COALITION | LMH STRATEGIC SOLUTIONS | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 25 | 2 |
| 2025 | 23 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 6 | $16K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Alanna Temme. See the Capitol Clarity rankings and method.